Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Anika completes patient enrollment in Orthovisc phase III trial

Aug. 24, 1999

Fuji Pharmaceutical describes therapeutic activity of dual MMP/TACE inhibitors

Aug. 19, 1999

Etanercept trial results in psoriatic arthritis announced

Aug. 18, 1999

COX-2 inhibitor research continues at Searle

Aug. 17, 1999

Iomed begins phase III trials of IontoDex for inflammation

Aug. 16, 1999

MMP-3-selective matrix metalloproteinase inhibitors discovered at Pfizer

Aug. 13, 1999

Phase II trial commences for Alexion's C5 complement inhibitor in RA

Aug. 12, 1999

Novel NSAIDs synthesized and evaluated at Ortho-McNeil

Aug. 11, 1999

Merck launches COX-2 inhibitor in the U.K.

Aug. 5, 1999

Daiichi reports novel cytokine production inhibitors in patent literature

Aug. 4, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...